The second edition of “Pharmacoresistance in Epilepsy” is a comprehensive resource that delves into the various aspects of drug-resistant epilepsy. It offers a thorough exploration of the subject, covering both clinical studies in patients and experimental models to provide a well-rounded understanding of the latest developments in the pathogenesis and treatment of this condition.
This edition addresses key issues related to drug-resistant epilepsy, including abnormalities in inhibitory mechanisms, neurotoxicity, and immune system changes associated with the disorder. It also delves into the development of drug resistance resulting from chronic exposure to antiseizure medications.
Recognizing that traditional antiseizure medications often fail to control epilepsy associated with drug resistance, the book presents therapeutic strategies to prevent or mitigate the progression of the disease through complementary medical therapies. This includes innovative approaches like transcranial focal stimulation aimed at promoting neuroprotection.
“Pharmacoresistance in Epilepsy” serves as a valuable resource for a wide range of professionals in the field, whether they are conducting research on epilepsy in a laboratory setting or providing clinical care to patients with epilepsy. It offers insights and strategies to better understand and address drug-resistant epilepsy, making it an essential reference for those working with this challenging condition.
